Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Patients Deserve Price Tags Act
Client: U.S. PUBLIC INTEREST RESEARCH GROUP · Firm: U.S. PUBLIC INTEREST RESEARCH GROUP
In support of S.2355/H.R.5582 Patients Deserve Price Tags Act, in support of health care price transparency; Generic Drug User Fee Amendments (GDUFA); Prescription Drug User Fee Act (PDUFA)
Patients Deserve Price Tags Act
Client: U.S. PUBLIC INTEREST RESEARCH GROUP · Firm: U.S. PUBLIC INTEREST RESEARCH GROUP
In support of S.2355/H.R.5582 Patients Deserve Price Tags Act, in support of health care price transparency; Generic Drug User Fee Amendments (GDUFA); Prescription Drug User Fee Act (PDUFA)
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
U.S. PUBLIC INTEREST RESEARCH GROUP via U.S. PUBLIC INTEREST RESEARCH GROUP
2026 · first_quarter · Q1
In support of S.2355/H.R.5582 Patients Deserve Price Tags Act, in support of health care price transparency; Generic Drug User Fee Amendments (GDUFA); Prescription Drug User Fee Act (PDUFA)
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA